Device Trial Radar · NCT03101007
RSA RCT: Attune RP TKA Versus LCS RP TKA
Last checked: Nov 19, 2026Latest source record: Apr 27, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
61
Actual
Start
Jul 25, 2017
Primary completion
Jun 5, 2021
Study completion Jun 5, 2021
Sponsor
- Lead sponsor
- Spaarne GasthuisAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Leiden University Medical Center
- First posted
- Apr 4, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The LCS Complete Cementless Knee by DePuy Synthes is a rotating platform knee replacement with a good clinical track record and good survival rates. The cementless ATTUNE Cruciate Sacrificing (CS) Rotating Platform Knee by DePuy Synthes has been designed to provide better range of motion and address the unstable feeling some patients experience during everyday activities, such as stair descent and bending. It is expected that the cementless ATTUNE Rotating Platform Knee will have regulatory approval early 2016. Patient inclusion will start after regular approval has been obtained. The objective of this study is to accurately assess and compare migration, clinical and radiological outcome and patient reported outcomes (PROMS) of two TKR prostheses: the Cementless ATTUNE Rotating Platform Cruciate Sacrificing Knee System and the LCS Complete Cementless Cruciate Sacrificing Knee System (rotating platform design), both by DePuy Synthes, Warsaw, Indiana, USA. In this single-blind, randomized non-inferiority trial, 32 patients with the ATTUNE Knee System and 32 patients with LCS Knee System will be included. The study population will consist of patients with symptomatic osteoarthritis of the knee scheduled for TKR surgery at the Department of Orthopaedics, Spaarne Gasthuis, Hoofddorp, The Netherlands. Annually 300 TKA procedures are performed in this department, of which about 95% is Osteo Arthritis (OA). The investigator anticipates that inclusion can be accomplished within a 1 year period and that the total study duration is 3 years. Main study parameters/endpoints are: * Migration, measured by means of RSA. * Patient Reported Outcome Measures by means of questionnaires.
Conditions
- Osteoarthritis Arthritis
- Joint Disease
- Musculoskeletal Disease
Interventions
ATTUNE Knee Prosthesis by DePuyDevice
Total Knee Replacement (TKR) Surgery with cementless ATTUNE rotating platform Knee Prosthesis by DePuy
LCS Knee Prosthesis by DePuyDevice
Total Knee Replacement Surgery with cementless LCS rotating platform Knee Prosthesis by DePuy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Migration, measured by means of RSATime frame: 2 Years
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Spaarne Gasthuis
Hoofddorp, Netherlands
Leiden University Medical Center
Leiden, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.